Moderna announced on Tuesday a deal with the US government to fund a late-stage trial of its pandemic bird flu vaccine. The announcement comes after months of speculation surrounding the Cambridge ...

The US government ... a Phase 3 trial, anticipated to begin in 2025. The funding deal will support late-stage development of a "pre-pandemic vaccine against H5 influenza virus," Moderna said.

The US Department of Health and Human Services announced Tuesday a contract with Moderna to develop an mRNA vaccine that targets pandemic flu, in case the shot becomes necessary with the latest ...

Moderna Inc. secured nearly $200 million from the US government to speed development of an mRNA vaccine for pandemic influenza as a dangerous strain of bird flu sweeps through the nation’s dairy ...

The U.S. Department of Health and Human Services announced Tuesday a contract with Moderna to develop an mRNA ... acting senior adviser for H5N1 response at the US Department of Agriculture ...